pharmaphorum6d
Novartis and GSK’s multi-billion dollar swaps to transform both companies
The four-pronged strategy begins with the acquisition of GSK's oncology portfolio ... health division to Lilly for $5.4 billion reflects major changes in the animal health market, sparked by ...
Yahoo Finance8d
GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report
No major differences ... and discounted brand-name drugs. The report provides estimated price thresholds that CMS should ...
Fierce Biotech10d
GSK gears up for depemokimab debut with twin FDA filings and phase 3 data dump
With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its ...
Business Insider India6y
A top executive at GSK reveals why it's prepared to ditch the brands that helped turn it into a $95 billion powerhouse
having the business as part of GSK gave it more stability, letting the pharma side of the business take more risks. Read more: Two huge drugmakers are spinning off iconic brands like Advil ...
Warc2y
Pain relief: How GSK is using semiotics to take the headache out of brand strategy
GSK has drawn on a vast bank of images and conversations from ... In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with ...